Prof. Ferenc Darvas acquired his degrees in Budapest, Hungary (medicinal chemistry MS, computer sciences BS, PhD in experimental biology). He has been teaching in Hungary, Spain, Austria, and in the USA. Dr. Darvas has been involved in introducing microfluidics/flow chemistry methodologies for synthetizing drug candidates since the late 90’s, which led him to found ThalesNano, the inventor of H-Cube®, and has been awarded three times with R&D100 (“Technical Oscar”).

Dr. Darvas was awarded Senator Honoris Cause by the University of Szeged, Hungary (2019), and as Fellow of the American Chemical Society (2016). Dr. Darvas is also the founder and active President of the Flow Chemistry Society, Switzerland, founder and Editorial Board member of the Journal of Flow Chemistry, founder of the Space Chemistry Consortium, organizer of the Space Chemistry Symposium series at ACS, and initiator of the world-first anti-Covid drug discovery experiments on ISS.

Prof Paul Watts started his career as a lecturer at the University of Hull in 2002, being promoted to full professor in 2011. At the University of Hull he led the micro reactor and flow technology group. In February 2013, he moved to Nelson Mandela University to hold the distinguished position of ‘Research Chair in Microfluidic Bio/Chemical Processing’.  He has published of over 120 highly cited papers. He strongly believes that scientists should conduct research that impacts society; the biggest project underway involves the local production of key drugs as the morbidity and mortality from major diseases are much more devastating in Africa than in other regions of the world.  The vision is that new technology will be used within South Africa to manufacture generic drugs; this could create jobs and a new manufacturing industry within the country. 

Mr Robert Ashe is a Chemical Engineer with over 40 years’ experience in chemical plant design and operation. He co-founded AM Technology (AMT) 17 years ago to specialize in reactor design and control. For the past 10 years, the company has specialised in flow reactors and are now the global leader in actively mixed flow reactors. AMT have won awards for innovation from the Institution of Chemical Engineers and a Kirkpatrick Honour Award which is granted for noteworthy chemical-engineering technology. Mr Robert has contributed to and authored numerous articles, papers, patents and conferences on the subject of flow chemistry. He is currently the managing director of AMT but remains actively involved in flow reactor research and development.

Starting her research in the area of continuous flow synthesis in 2000, Dr Charlotte obtained her PhD in 2003 entitled ‘Microreactors in organic synthesis’. This was followed by 5 years of Post Doctoral research into the rapidly developing field of continuous flow synthesis, specifically in the area of heterogeneous catalysis for small molecule synthesis. 
In 2008, Dr Charlotte Wiles joined Chemtrix BV as a Senior Chemist where she worked on the commercialisation of lab-scale micro reactor apparatus. In 2010 she was promoted to Chief Technology Officer within Chemtrix BV and in 2013 to CEO, where she continues to research and develop continuous flow systems and solutions for industrial partners; with more recent developments focusing on industrial flow reactors, suited towards the development of flexible tonne-scale production plants, in cooperation with 3M and DSM. 
Over the course of her research career, Dr Charlotte has published more than 60 peer-reviewed articles, several book chapters and in 2011 published a book ‘Micro reaction technology in organic synthesis’.

Dr Thomas Wirth is professor of organic chemistry at Cardiff University. After studying chemistry in Bonn/Germany and at the Technical University of Berlin/Germany, he obtained his PhD in 1992 with Professor S. Blechert. After a postdoctoral stay with Professor K. Fuji at Kyoto University a JSPS fellow, he started his independent research at the University of Basel/Switzerland. In the group of Professor B. Giese he obtained his habilitation on stereoselective oxidation reactions supported by various scholarships before taking up his current position at Cardiff University in 2000. He was invited as a visiting professor to a number of places including the University of Toronto/Canada (1999), Chuo University in Tokyo, Osaka University, Osaka Prefecture University and with a JSPS fellowship to Kyoto University (2012). He was awarded the Werner-Prize from the New Swiss Chemical Society (2000), the Furusato award from JSPS London (2013) and recently the Wolfson Research Merit Award from the Royal Society and the Bader Award from the Royal Society of Chemistry (2016). In 2016 he was elected as a fellow of The Learned Society of Wales. His main interests of research concern stereoselective electrophilic reactions, oxidative transformations with hypervalent iodine reagents including mechanistic investigations and organic synthesis performed in microreactors.

Dr Stephen G. Newman earned his doctoral degree in chemistry in 2012 at the University of Toronto in the group of Prof. Mark Lautens. After carrying out an NSERC Postdoctoral Fellowship with Prof. Klavs Jensen at the Massachusetts Institute of Technology, he joined the faculty at the University of Ottawa in 2014 where he holds the Tier 2 anada Research Chair in Sustainable Catalysis. He and his research group seek to improve the efficiency of chemical synthesis by the application of new technologies and the development of novel catalytic methods

Mr. Vijay Kirpalani, Founder President, Flow Chemistry Society – India Chapter has obtained his B.E. (Chemical Engg.) from Maharaja Sayajirao University, Baroda. He is also a CEO, Pi-Process Intensification Experts LLP; Director of Sharon Bio-Medicine Ltd. As well as ChemSphere Consultants P. Ltd.; Partner, ChemSphere Technologies and Director, Mehta API (P) Ltd.
He is expert in Process Intensification, Flow Chemistry, Bio-catalysis, Process Design & Execution (of cGMP HAPI / API / Pharma Formulation, Chemical, Fine-Chemical, Biotech & Nanotech Facilities), QbD, PAT, Reg Affairs. He has Experience with an extensive repertoire of process technologies that have been developed and commercialized across over 100 grass-roots plants with > 200 processes in 14 countries.
In 2012, he conceived the scheme and led the Team as Director & Head – receiving a Grant of Rs. 6.9o Cr from DSIR (under the Technology-Development&Demo Programme) for development of Enzymes and Chemo-enzymatic methods to Chiral APIs & Intermediates including setting-up of a state-of-the-art biotech laboratory.
He had also Worked with BARC (Bhabha Atomic Research Center), Bharat Petroleum, IPCL, United Phosphorous Ltd., Baroda Productivity Council, etc.

Dr. Manuel Nuño completed his MChem at Universidad de Zaragoza, Spain and York University, UK moving to University of Bath, UK to undertake his PhD in photocatalysis under the supervision of Dr Richard J. Ball.

Following completion of his PhD, Manuel advanced his process improvement skills during three years as process development chemist in food manufacturing industry working to improve the performance of large scale batch and flow chemical processes involving extraction, purification and crystallisation of sugars. Currently Manuel works at Vapourtec ltd as Chief Scientific Officer, offering applications and chemistry support to customer and product development teams. Projects he has worked with include, photochemistry in flow, flow peptide synthesis, organometallic chemistry in flow and continuous electrochemical oxidation of natural products.

Dr. Srividya Ramakrishnan heads Process Engineering(API) at Dr. Reddy’s Laboratories Ltd. in Hyderabad.She earned her B.Tech. in Chemical Engineering from Indian Institute of Technology, Madras, and Ph.D. from Princeton University, USA. Prior to joining Dr. Reddy’s, she worked at Unilever Research followed by Bristol-Myers Squibb in New Jersey. Srividyahas brought in innovative, continuous manufacturing technologies that would enable greater sustainability with lower cost. She has presented her research at international conferences, has several patents and publications to her credit and is also an ASQ-Certified Six Sigma Black Belt. Since last year, she has taken up an additional role as Chief Diversity Officer at Dr. Reddy’s. Srividya is passionate about women’s empowerment and was instrumental in drafting policies to enable work-life integration (recognized for Leadership Commitment at UN Women India 2020 WEPs awards).